Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
11/1979
11/06/1979US4173632 5(6)-alkylbenzimidazolecarbamates, tribromosalan
11/06/1979CA1065855A1 Virtually solvent-free crystal form of the sodium salt of cephacetril
10/1979
10/30/1979US4172894 3-Thienyl-3-methyl-4-pentyl-2-pyridyl-ketone
10/30/1979US4172892 Heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid
10/30/1979US4172891 Antibiotics
10/30/1979CA1065329A1 Chromone derivatives
10/30/1979CA1065317A1 Catalytic dehalogenation process for preparing 2-(4- (2- furoyl) piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
10/30/1979CA1065304A1 PROCESS FOR PREPARING 7.beta.-ACYLAMINO-7.alpha.-ALKOXYCEPHALOSPORINS
10/23/1979CA1064924A1 Tricyclic dibenzazepine derivatives
10/23/1979CA1064909A1 Preparation of 3-methoxymethylcephalosporins
10/16/1979CA1064500A1 1,4-dithlino(2,3-c; 6, -c')diisothiazole and related compounds
10/09/1979CA1064054A1 Process for the manufacture of 3-aminophenols by dehydrogenation of 3-aminocyclohexenones
10/09/1979CA1064042A1 Process for the preparation of benzamide derivatives
09/1979
09/25/1979US4169201 Antitumor agents, anticarcinogenic agents
09/25/1979CA1063114A1 Cinnolin-3-yl carboxylic acids, ester and amides
09/25/1979CA1063107A1 Process for producing 2-substituted 1,4-benzodiazepine derivatives
09/25/1979CA1063027A1 Substituted n-(1-(3,4-methylendioxyphenyl)-propyl(2))-n'-substituted phenylpiperazines
09/19/1979EP0004018A1 1-Oxa-4-aza-2,6-disilacyclohexanes, their production and use as muscle relaxants and pharmaceutical compositions containing them
09/18/1979US4168376 Hydrolysis of o-formyl ester in methanol
09/18/1979US4168375 Process for the recovery of cephalosporin C and derivatives thereof
09/18/1979US4168309 Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
09/18/1979US4168272 Homologs of lasalocid A
09/18/1979CA1062654A1 Process for preparing 3-methylene cephalosporins
09/11/1979US4167572 N-6-Chloronicotinoyl-d,l-homocysteine thiolactone
08/1979
08/28/1979CA1061343A1 Substituted n-(1-(3,4-methylendioxyphenyl)-propyl(2))-n'-substituted phenylpiperazines
08/21/1979US4165429 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
08/21/1979US4165315 Sulfinyl halides and their preparation from penicillin sulfoxides
08/14/1979CA1060464A1 Pesticidal triazapentadienes
08/14/1979CA1060454A1 7-methoxycephalosporin derivatives
08/14/1979CA1060445A1 Process for preparing quinazoline derivatives
08/07/1979CA1059990A1 7 .alpha.-ALKOXYCEPHALOSPORIN DERIVATIVES AND THEIR PREPARATION
08/07/1979CA1059989A1 Cephamycins
07/1979
07/31/1979CA1059516A1 Hydratropic acid derivatives and process for the production thereof
07/24/1979US4162255 Process for extracting aristolochic acids
07/10/1979CA1058207A1 Thioacylalanine derivatives
07/03/1979US4160086 3-Heterocyclicthio-7-α-carboxy 2-aryl acetamido cephalosporanic acid
07/03/1979US4159991 Imidation of acyloxymalononitrile, acid catalyst, bleaches, scouring
07/03/1979CA1057755A1 Heterocyclic compounds, their preparation and compositions thereof_
07/03/1979CA1057739A1 Pyridinylthiomethyl derivatives of cyanomethylthioacetyl cephalosporins
06/1979
06/27/1979EP0002605A1 Cephalosporin compounds and formulations containing them for use in the treatment of bacterial infections and the preparation of the cephalosporin compounds
06/26/1979CA1057283A1 3-carbamoyloxymethyl-7-(2-(fur-2-yl)-2-methoxyiminoacetamido) ceph-3-em-4-carboxylic acid
06/26/1979CA1057282A1 Process for making cephalosporins
06/19/1979CA1056816A1 Process for the conversion of 6-aminopenicillanic acid (6-apa) in 7-aminodesacetoxycephalosporanic acid (7-adca)
05/1979
05/29/1979US4156724 N-acylamino-alpha-arylacetamido cephalosporins and antibacterial compositions and methods containing them
05/29/1979CA1055522A1 N,n"-thiobis (dithiobis) n'-aryl-n-methylformamidine derivatives
05/22/1979CA1055033A1 2-(2-heterocyclic-methylsulphinyl)-benzimidazole compounds
05/16/1979EP0001900A1 9-Thia-12-azaprostanoic acid derivatives and compositions containing them
05/15/1979US4154830 Unsaturated derivatives of 7-acylamido-3-cephem-4-carboxylic acid
05/08/1979US4153693 1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections
05/02/1979EP0001618A2 Process for the preparation of di-N-oxides and their pharmaceutical use
05/01/1979US4152348 Inhibition of color formation on storage
04/1979
04/24/1979CA1053243A1 Imidazolidine derivatives
04/17/1979US4150028 Antiviral thiazolinyl benzimidazoles
04/17/1979CA1052787A1 1-oxacephems and intermediates therefor
04/17/1979CA1052769A1 Process for preparing cefazolin
04/10/1979CA1052383A1 Process for the production of 1,2,4-triazole derivatives
04/10/1979CA1052381A1 Heterocyclic substituted fluorans
04/04/1979EP0001294A1 Lasalocide derivatives, their preparation and intermediates, and the pharmaceutical preparations containing them
04/04/1979EP0001238A1 Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation
04/03/1979US4147788 Antibacterials: 1-difluoromethyl-6,7-methylenedioxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its esters
04/03/1979CA1051800A1 Homologs of antibiotic lasalocid a from streptomyces
03/1979
03/27/1979CA1051432A1 Pyrimidinylureas
03/21/1979EP0001149A1 Process for the preparation of 3-bromomethyl-3-cephem-sulphoxide derivatives
03/21/1979EP0001144A1 N-substituted 2-hydrazono-propionic acid derivatives, process for their preparation and pharmaceutical compositions containing them
03/21/1979EP0001133A1 Process for the preparation of 6- D-alpha-amino-(p-hydroxyphenyl)-acetamido penicillanic acid
03/20/1979US4145550 Chemical intermediates for b-adrenergic blocking agents
03/20/1979CA1051029A1 Cyclohexenyl compounds
03/20/1979CA1051027A1 Process for the production of new phenylformamidines
03/20/1979CA1051011A1 Monoepoxyendooxycyclohexyl compounds useful as acid scavengers
03/20/1979CA1050979A1 Process for purifying cyanuric acid
03/20/1979CA1050971A1 Process for the preparation of ampicillin derivatives substituted by heterocyclic acyl group
03/20/1979CA1050970A1 PROCESS FOR THE PRODUCTION OF 7-(D-(.alpha.-AMINO)-PHENYLACETAMIDO)-3-DESACETOXY-CEPHALOSPORANIC ACID
03/20/1979CA1050969A1 CRYSTALLINE SESQUIHYDRATE OF 7-(D-AMINO-.alpha.-(P-HYDROXYPHENYL) ACETAMIDO)-3-(1,2,3,-TRIAZOL-5-YITHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID
03/13/1979US4144346 Fungicides, bactericides
03/13/1979CA1050545A1 Herbicidally active triazin-derivatives
03/13/1979CA1050430A1 Azole antimycotics and their use in treating skin conditions caused by pityrosporum ovale
03/07/1979EP0001006A1 Carboalkylated derivatives of acylated ethylene diamines, process for their preparation and surface-active compositions
02/1979
02/27/1979CA1049539A1 Substituted benzofuranyl esters
02/27/1979CA1049500A1 PROCESS FOR THE PREPARATION OF 7.alpha.-ALKOXY-3-CEPHEM COMPOUNDS
02/27/1979CA1049282A1 Synergistic compositions
02/20/1979US4140854 Antisecretory, antiulcer
02/20/1979US4140781 Analgesic and neuraleptic 2-piperidinoalkyl-1,4-benzodioxans
02/20/1979CA1049023A1 Carbamates and their use as pharmaceuticals
02/20/1979CA1048997A1 Cephalosporin derivatives
02/13/1979US4139703 Indole cephalosporin derivatives
02/13/1979US4139702 Borating, acylation, hydrolysis
02/13/1979US4139618 Cephalosporin type antibacterials
02/13/1979CA1048500A1 Process for the preparation of cyanuric acid
01/1979
01/30/1979US4137263 Process for the evaporation of cyclohexanone oxime
01/30/1979CA1047534A1 Haloacetanilides for influencing plant growth
01/30/1979CA1047509A1 Polymers of silybin
01/09/1979US4133888 Analgesic and morphine antagonistic 2'-hydroxy-2-(5-isoxazolyl-methyl)-6,7-benzomorphans and salts thereof
01/02/1979US4132849 Selective acid hydrolysis of a 3-formyloxymethyl cephalosporin
12/1978
12/20/1978EP0000005A1 New cephalosporin derivatives, their preparations and their pharmaceutical compositions
12/19/1978US4130566 Process for producing 5-carboxy-2-acetylthiophene
12/19/1978US4130558 Process for preparation of alkali metal salts of ampicillin
12/12/1978US4129731 Process for converting 3-methylene cephalosporins to 3-heterothiomethyl cephalosporins
12/12/1978US4129661 4,5-Dihydro-2-lower alkoxycarbonylamino-4-phenylimidazoles and substituted phenyl derivatives thereof
12/05/1978US4128547 Tertiary amine catalyst
12/05/1978CA1043793A1 Alpha-isomer of the palmitic acid ester of 10-(3-(4-hydroxyethyl-1-piperazinyl) propylidene)-2-trifluoromethyl thiaxanthene, compositions thereof and a method of preparation thereof
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105